Drug-Drug Interactions Between HMG-CoA Reductase Inhibitors (Statins) and Antiviral Protease Inhibitors.
- Published in:
- Clinical Pharmacokinetics, 2013, v. 52, n. 10, p. 815, doi. 10.1007/s40262-013-0075-4
- By:
- Publication type:
- Article
Works matching IS 03125963 AND DT 2013 AND VI 52 AND IP 10
Results: 7
1
2
Population Pharmacokinetic Analysis for Hydrocodone Following the Administration of Hydrocodone Bitartrate Extended-Release Capsules.
- Published in:
- Clinical Pharmacokinetics, 2013, v. 52, n. 10, p. 907, doi. 10.1007/s40262-013-0081-6
- By:
- Publication type:
- Article
3
The Relationship Between Fluticasone Furoate Systemic Exposure and Cortisol Suppression.
- Published in:
- Clinical Pharmacokinetics, 2013, v. 52, n. 10, p. 885, doi. 10.1007/s40262-013-0078-1
- By:
- Publication type:
- Article
4
The Role of Pharmacogenetics in Drug Disposition and Response of Oral Glucose-Lowering Drugs.
- Published in:
- Clinical Pharmacokinetics, 2013, v. 52, n. 10, p. 833, doi. 10.1007/s40262-013-0076-3
- By:
- Publication type:
- Article
5
Pharmacokinetics and Pharmacokinetic-Pharmacodynamic Correlations of Therapeutic Peptides.
- Published in:
- Clinical Pharmacokinetics, 2013, v. 52, n. 10, p. 855, doi. 10.1007/s40262-013-0079-0
- By:
- Publication type:
- Article
6
Antimicrobial Treatment of Febrile Neutropenia: Pharmacokinetic-Pharmacodynamic Considerations.
- Published in:
- Clinical Pharmacokinetics, 2013, v. 52, n. 10, p. 869, doi. 10.1007/s40262-013-0086-1
- By:
- Publication type:
- Article
7
Impact of Impaired Renal Function on the Pharmacokinetics of the Antiepileptic Drug Lacosamide.
- Published in:
- Clinical Pharmacokinetics, 2013, v. 52, n. 10, p. 897, doi. 10.1007/s40262-013-0080-7
- By:
- Publication type:
- Article